Articles involving Asia Region | CenterWatch News Online

Asia

1 2 3 4 5 6 7 8

Merck establishes R&D headquarters in China

Tuesday, December 6, 2011 01:10 PM

Merck, known as MSD outside the United States and Canada, has established an Asia research & development headquarters for innovative drug discovery and development located in Beijing, China. The new facility is part of a $1.5 billion commitment the company has made to invest in R&D in China over the next five years.

More... »

China Health Resources completes research project developing innovative medicines

Monday, December 5, 2011 09:59 AM

China Health Resource, through its wholly owned subsidiary Suining Yinfa, has completed a key scientific research project in collaboration with Chengdu Chinese Traditional Medicine & Science University and the Sichuan Chinese Medicine Research Institute.

More... »

RaySearch enters agreement with Chinese distributor

Tuesday, November 29, 2011 12:55 PM

RaySearch Laboratories has entered into an exclusive distribution agreement with the Chinese distributor Kang Li Da Trading, based in Beijing. The agreement means that Kang Li Da will be fully responsible for marketing, sales and service for RaySearch’s proprietary treatment planning system RayStation on the entire Chinese market.

More... »

RaySearch signs South Korean distribution agreement with OTS

Wednesday, November 23, 2011 11:04 AM

RaySearch Laboratories has entered into an exclusive distribution agreement with the South Korean distributor Oncology Total Solution, based in Seoul. The agreement means that OTS will be fully responsible for marketing, sales and service for RaySearch’s proprietary treatment planning system RayStation on the South Korean market.

More... »

Shire partners with Shionogi to develop ADHD medicines

Friday, November 18, 2011 11:48 AM

Shire has entered into an agreement with Shionogi & Co. of Japan to co-develop and co-commercialize certain of Shire's Attention Deficit Hyperactivity Disorder (ADHD) medicines in Japan. Shionogi will pay a one time fee and share costs with Shire in exchange for rights to jointly co-develop and co-commercialize the products upon approval for the Japanese market. Specific terms of the agreement are not being disclosed.

More... »

inVentiv expands services to Korea

Thursday, November 10, 2011 09:28 AM

inVentiv Health has established inVentiv Health Korea, a Seoul-based operation that will provide clinical development and commercial services to healthcare clients.

More... »

Quin joins Asymchem as VP, medicinal chemistry

Thursday, November 3, 2011 01:31 PM

Asymchem Life Science has named Dr. Li Qun vice president of medicinal chemistry. His responsibilities include managing FTE work in medicinal and preclinical synthetic chemistry, based out of TEDA Tianjin.

More... »

WuXi PharmaTech acquires two clinical research companies in China

Monday, October 24, 2011 11:44 AM

WuXi PharmaTech has acquired MedKey Med-Tech Development and Jiecheng Med-Tech Development, two related contract clinical research services companies based in Shanghai, China. The financial terms of the transaction were not disclosed.

More... »

ShangPharma acquires Charles River’s Shanghai facility

Monday, October 24, 2011 10:49 AM

ShangPharma, a China-based pharmaceutical and biotechnology research and development outsourcing company, has acquired the assets in Charles River Laboratories International’s Shanghai research facility.

More... »